Health Care Whistleblower Protection Act
HB337 creates the Health Care Whistleblower Protection Act, a new state law designed to protect people who report unlawful, unsafe, fraudulent, or improper conduct by health care entities. The bill defines a broad set of covered entities and individuals, including hospitals, health care providers, telemedicine providers, staffing companies, management services organizations, and other health care facilities, while excluding federally qualified health centers and independent health care practices. It also defines whistleblowers broadly to include patients, family members, volunteers, consumers, employees, contractors, subcontractors, board members, and agents who disclose misconduct in good faith.
The bill prohibits health care entities from taking retaliatory action against whistleblowers who report concerns to government agencies, testify in proceedings, or refuse to participate in conduct they reasonably believe is unlawful or improper. It requires whistleblower identities to remain confidential unless disclosure is authorized in writing. The bill also requires health care entities to adopt and post whistleblower protection policies in English and Spanish, provide notice to workers and agents, and make the policy visible to patients, residents, volunteers, employees, and visitors. The act would take effect July 1, 2025.
HB337 would add a new statutory cause of action in New Mexico law for retaliation against health care whistleblowers. It authorizes civil lawsuits for damages, reinstatement, back pay, special damages, attorney fees, and litigation costs for covered whistleblowers, and it allows non-employee whistleblowers to seek injunctions and damages as well. The bill also states that its remedies are not exclusive, cannot be waived by contract or employment policy, and are not displaced by arbitration agreements, collective bargaining agreements, or other legal remedies. Health care entities would need to update workplace policies and notices to comply with the new posting and disclosure requirements.
The bill appears generally supportive of whistleblower protections and patient safety, with its structure reflecting a strong policy preference for encouraging reporting of misconduct in health care settings. Because no committee transcripts or recorded votes were provided, there is no direct evidence of debate, amendment activity, or partisan division in the available materials. On its face, the bill is framed as a consumer- and worker-protection measure rather than a regulatory rollback or expansion of health care services.
The main points of potential contention are the bill’s broad reach and its enforcement provisions. Health care entities may object to the wide definition of covered facilities and personnel, the inclusion of telemedicine and staffing companies, and the fact that arbitration agreements and employment conditions cannot waive the act’s protections. Another likely issue is the scope of protected conduct, which includes not only illegal acts but also unsafe, fraudulent, wasteful, or abusive practices and substantial dangers to patients or the public. The bill also creates liability exposure through damages, reinstatement, fee shifting, and injunctions, which could concern employers and health system operators, while supporters would likely emphasize confidentiality and anti-retaliation safeguards for patients and workers.